Preimplantation genetic testing for aneuploidy: costly or cost effective?

Reflections

Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine
Published
Like Comment

Volume 110, Issue 5, Page 851

Authors:

Jared C. Robins, M.D, Dana B. McQueen, M.D.

Abstract:

Reflections on "Preimplantation genetic testing for aneuploidy (PGT-A) is cost effective, shortens treatment time, and reduces the risk of failed embryo transfer and clinical miscarriage in select patients when compared to IVF alone" by Neal et al.


Read the full text here.

Go to the profile of Fertility and Sterility

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.